본문 바로가기
KERD
논문KCI 등재

Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

2

조회

0

다운로드

6

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Acinetobacter baumannii has a greater clinical impact and exhibits higher antimicrobial resistance rates than the non-baumannii Acinetobacter species. Therefore, the correct identification of Acinetobacter species is clinically important. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) has recently become the method of choice for identifying bacterial species. The purpose of this study was to evaluate the ability of MALDI-TOF MS (Bruker Daltonics GmbH, Germany) in combination with an improved database to identify various Acinetobacter species. Methods: A total of 729 Acinetobacter clinical isolates were investigated, including 447 A. baumannii, 146 A. nosocomialis, 78 A. pittii, 18 A. ursingii, 9 A. bereziniae, 9 A. soli, 4 A. johnsonii, 4 A. radioresistens, 3 A. gyllenbergii, 3 A. haemolyticus, 2 A. lwoffii, 2 A. junii, 2 A. venetianus, and 2 A. genomospecies 14TU. After 212 isolates were tested with the default Bruker database, the profiles of 63 additional Acinetobacter strains were added to the default database, and 517 isolates from 32 hospitals were assayed for validation. All strains in this study were confirmed by rpoB sequencing. Results: The addition of the 63 Acinetobacter strains’ profiles to the default Bruker database increased the overall concordance rate between MALDI-TOF MS and rpoB sequencing from 69.8% (148/212) to 100.0% (517/517). Moreover, after library modification, all previously mismatched 64 Acinetobacter strains were correctly identified. Conclusions: MALDI-TOF MS enables the prompt and accurate identification of clinically significant Acinetobacter species when used with the improved database.

Abstract

Background: Acinetobacter baumannii has a greater clinical impact and exhibits higher antimicrobial resistance rates than the non-baumannii Acinetobacter species. Therefore, the correct identification of Acinetobacter species is clinically important. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) has recently become the method of choice for identifying bacterial species. The purpose of this study was to evaluate the ability of MALDI-TOF MS (Bruker Daltonics GmbH, Germany) in combination with an improved database to identify various Acinetobacter species. Methods: A total of 729 Acinetobacter clinical isolates were investigated, including 447 A. baumannii, 146 A. nosocomialis, 78 A. pittii, 18 A. ursingii, 9 A. bereziniae, 9 A. soli, 4 A. johnsonii, 4 A. radioresistens, 3 A. gyllenbergii, 3 A. haemolyticus, 2 A. lwoffii, 2 A. junii, 2 A. venetianus, and 2 A. genomospecies 14TU. After 212 isolates were tested with the default Bruker database, the profiles of 63 additional Acinetobacter strains were added to the default database, and 517 isolates from 32 hospitals were assayed for validation. All strains in this study were confirmed by rpoB sequencing. Results: The addition of the 63 Acinetobacter strains’ profiles to the default Bruker database increased the overall concordance rate between MALDI-TOF MS and rpoB sequencing from 69.8% (148/212) to 100.0% (517/517). Moreover, after library modification, all previously mismatched 64 Acinetobacter strains were correctly identified. Conclusions: MALDI-TOF MS enables the prompt and accurate identification of clinically significant Acinetobacter species when used with the improved database.

참고문헌 (31)

  1. Espinal P, "Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter", Future Microbiol, 6, pp.495~511 (2011)
  2. Kishii K, "Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures", Clin Microbiol Infect, 20, pp.424~430 (2014)
  3. Lockhart SR, "Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004", J Clin Microbiol, 45, pp.3352~3359 (2007)
  4. Kempf M, "Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options", Int J Antimicrob Agents, 39, pp.105~114 (2012)
  5. Fournier PE, "The epidemiology and control of Acinetobacter baumannii in health care facilities", Clin Infect Dis, 42, pp.692~699 (2006)
  6. Chen SF, "Adult Acinetobacter meningitis and its comparison with non-Acinetobacter gram-negative bacterial meningitis", Acta Neurol Taiwan, 14, pp.131~137 (2005)
  7. Tsai HY, "Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010", Eur J Clin Microbiol Infect Dis, 31, pp.2737~2743 (2012)
  8. Castellanos Martínez E, "Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus", Infection, 23, pp.243~245 (1995)
  9. Molina J, "Clinical features of infections and colonization by Acinetobacter genospecies 3", J Clin Microbiol, 48, pp.4623~4626 (2010)
  10. Wisplinghoff H, "Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility", Clin Infect Dis, 31, pp.690~697 (2000)
  11. Chuang YC, "Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia", Clin Infect Dis, 52, pp.352~360 (2011)
  12. Turton JF, "Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species", J Clin Microbiol, 48, pp.1445~1449 (2010)
  13. 이경원, "Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens", Yonsei Medical Journal, 52(6), pp.879~891 (2011), 연세대학교의과대학
  14. Wang J, "Species distribution of clinical Acinetobacter isolates revealed by different identification techniques", PLoS One, 9, pp.e104882~ (2014)
  15. Chang HC, "Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region", J Clin Microbiol, 43, pp.1632~1639 (2005)
  16. Gundi VA, "Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species", Microbiology, 155, pp.2333~2341 (2009)
  17. La Scola B, "Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species", J Clin Microbiol, 44, pp.827~832 (2006)
  18. Carbonnelle E, "MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory", Clin Biochem, 44, pp.104~109 (2011)
  19. Murray PR, "What is new in clinical microbiology-microbial identification by MALDI-TOF mass spectrometry: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology", J Mol Diagn, 14, pp.419~423 (2012)
  20. Espinal P, "Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS", Clin Microbiol Infect, 18, pp.1097~1103 (2012)
  21. Jeong S, "Evaluation of peptide nucleic acid-mediated multiplex real-time PCR kits for rapid detection of carbapenemase genes in gram-negative clinical isolates", J Microbiol Methods, 113, pp.4~9 (2015)
  22. Hsueh PR, "Evaluation of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of blood isolates of Acinetobacter species", J Clin Microbiol, 52, pp.3095~3100 (2014)
  23. Šedo O, "Improvement of MALDI-TOF MS profiling for the differentiation of species within the Acinetobacter calcoaceticus-Acinetobacter baumannii complex", Syst Appl Microbiol, 36, pp.572~578 (2013)
  24. Donnarumma F, "Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis", J Clin Microbiol, 48, pp.1297~1304 (2010)
  25. Máder K, "Outbreak of septicaemic cases caused by Acinetobacter ursingii in a neonatal intensive care unit", Int J Med Microbiol, 300, pp.338~340 (2010)
  26. Idzenga D, "Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit", J Hosp Infect, 63, pp.485~487 (2006)
  27. van Dessel H, "Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit", J Hosp Infect, 51, pp.89~95 (2002)
  28. Park KH, "The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies", PLoS One, 8, pp.e65026~ (2013)
  29. Lin YC, "Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan", Int J Antimicrob Agents, 35, pp.439~443 (2010)
  30. Lee YT, "Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan", Int J Antimicrob Agents, 34, pp.580~584 (2009)
  31. Nemec A, "Variations in colistin susceptibility among different species of the genus Acinetobacter", J Antimicrob Chemother, 65, pp.367~369 (2010)

관련 논문AI추천

Evaluation of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based VITEK MS System for the Identification of Acinetobacter Species from Blood Cultures: Comparison with VITEK 2 and MicroScan Systems김수현, 서순팔, 신명근, 신종희, 양동욱, 이승엽대한진단검사의학회 · Annals of Laboratory Medicine2015 · 제35권 제1호Performance of the ASTA MicroIDSys, a Novel MALDI-TOF MS Platform for Identifying Various Acinetobacter Species: Comparison with the Bruker Biotyper박건, 강성호, 고영진, 김수현, 김우신, 김춘미, 신종희, 이슬비, 이호종, 장숙진대한진단검사의학회 · Laboratory Medicine Online2022 · 제12권 제3호Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Clinical Microbiology: What Are the Current Issues?Alex van Belkum, David Pincus, Jean-Philippe Charrier, Martin Welker, Victoria Girard대한진단검사의학회 · Annals of Laboratory Medicine2017 · 제37권 제6호Comparison of a New Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Platform, ASTA MicroIDSys, With Bruker Biotyper for Species Identification김현수, 성지연, 용동은, 이경원, 이양순대한진단검사의학회 · Annals of Laboratory Medicine2017 · 제37권 제6호Substantial Improvement in Nontuberculous Mycobacterial Identification Using ASTA MicroIDSys Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry with an Upgraded Database이혁민, In Yongha, Kim Daewon, Lee Kyoungwon, Song Junhyup, Yong Dongeun, Yoon Shinyoung대한진단검사의학회 · Annals of Laboratory Medicine2022 · 제42권 제3호Evaluation of VITEK Mass Spectrometry (MS), a Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS System for Identification of Anaerobic Bacteria김명숙, 용동은, 이경원, 이원목, 정석훈, 정윤섭대한진단검사의학회 · Annals of Laboratory Medicine2015 · 제35권 제1호

이 간행물의 다른 논문 (20건)